Zoetis Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

Banque Transatlantique SA Trims Stake in Zoetis Inc. $ZTS

AI-generated analysis

πŸ“‰ Banque Transatlantique SA reduced its Zoetis stake by 26.2% in Q4, selling 62,912 shares while retaining 176,793 shares valued at $22.24 million.

πŸ“ˆ T. Rowe Price Investment Management Inc. increased its position by 3,311.3%, acquiring 153,611 additional shares worth $19.91 million in the fourth quarter.

πŸ’° MidFirst Bank established a new Zoetis position valued at approximately $633,000 during the same reporting period.

πŸ“Š Zoetis reported Q4 earnings of $1.53 EPS, missing analyst estimates of $1.60 by $0.07 despite revenue growth of 2.9% year-over-year.

πŸ’΅ The company declared a quarterly dividend of $0.53 per share with an ex-dividend date of July 20th and a payout ratio of 35.16%.

πŸ‘” Corporate insiders purchased 11,650 shares valued at $886,384 in the last three months, including significant buys by Directors Frank A. Damelio and Michael B. Mccallister.

πŸ“‰ Analyst sentiment is mixed with a consensus target price of $133.92, following recent downgrades from Wall Street Zen and Stifel Nicolaus to 'Hold' ratings.

🏒 Institutional ownership remains high at 92.80%, with other investors like Pacer Advisors boosting stakes by 18.3%.

Bullish Signals
  • T. Rowe Price Investment Management Inc. aggressively increased its Zoetis stake by over 3,300%, acquiring more than 150,000 shares in a single quarter.
  • Corporate insiders have been net buyers, purchasing $886,384 worth of stock in the last three months, signaling confidence from management and directors.
  • Zoetis achieved revenue growth of 2.9% year-over-year to reach $2.26 billion, demonstrating continued top-line expansion despite a slight earnings miss.
  • The company maintains a robust return on equity of 66.85% and a healthy net margin of 27.80%, indicating strong operational profitability.
  • MidFirst Bank initiated a new position in Zoetis valued at $633,000, adding to the list of institutional investors increasing or starting exposure.
Risk Factors
  • Zoetis reported fourth-quarter earnings of $1.53 per share, which missed the consensus analyst estimate of $1.60 by $0.07.
  • Quarterly revenue of $2.26 billion fell short of analyst expectations of $2.30 billion, indicating a slight shortfall in performance.
  • Recent analyst downgrades from Wall Street Zen and Stifel Nicolaus have lowered the stock's rating to 'Hold', reflecting cautious sentiment.
  • Banque Transatlantique SA significantly reduced its stake by 26.2%, selling over 62,000 shares during the fourth quarter.
Full Analysis
Banque Transatlantique SA reduced its stake in Zoetis Inc. (NYSE:ZTS) by 26.2% during the fourth quarter, selling 62,912 shares to hold a remaining position of 176,793 shares valued at $22.24 million. While Banque Transatlantique trimmed its exposure, several other institutional investors increased their holdings, including MidFirst Bank which established a new $633,000 position, and Pacer Advisors Inc. which boosted its stake by 18.3% to own 141,883 shares. T. Rowe Price Investment Management Inc. significantly expanded its Zoetis position by 3,311.3%, acquiring an additional 153,611 shares worth $19.91 million, while Strive Financial Group LLC and Beacon Pointe Advisors LLC also added to their stakes. Collectively, hedge funds and other institutional investors own 92.80% of the company's outstanding stock, indicating strong institutional interest despite the reduction by Banque Transatlantique. Zoetis recently reported fourth-quarter earnings of $1.53 per share, missing analyst consensus estimates of $1.60 by $0.07. The company generated revenue of $2.26 billion, which was 2.9% higher than the prior year but slightly below the expected $2.30 billion. Despite the miss, Zoetis maintained a strong return on equity of 66.85% and a net margin of 27.80%, with management providing full-year 2026 guidance for EPS between $6.85 and $7.00. The company announced a quarterly dividend of $0.53 per share, payable on September 1st to stockholders of record as of July 20th, representing an annualized yield of 2.7%. Recent insider activity includes Director Frank A. Damelio purchasing 6,650 shares for $501,343 and Director Michael B. Mccallister buying 3,000 shares for $233,280, totaling $886,380 in insider purchases over the last three months. Analyst ratings remain mixed with a consensus target price of $133.92, though recent downgrades from Wall Street Zen and Stifel Nicolaus have tempered bullish sentiment.